Xeris Biopharma Holdings, Inc.

By person

18 insiders · 61 transactions

33.1×

John Shannon holds 33.1 times base salary in stock. $24.64M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $8.50, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

JOHNSON JOHN

Director

—

$1.85M (3)

−$1.85M

707,276

0.3879%

$6.01M

—

Hecht Beth

See Remarks

—

$1.52M (13) scheduled

−$1.52M

1,127,796

0.6186%

$9.59M

+2,919%

McCulloch Kevin

See Remarks

$109.48K (1)

$1.09M (4) scheduled

−$980.58K

1,664,208

0.9128%

$14.15M

+11.6%

Edick Paul R

See Remarks

$654.60K (5)

—

+$654.60K

3,821,494

2.10%

$32.48M

—

HALKUFF DAWN

Director

$9.95K (1)

$431.11K (2)

−$421.16K

124,603

0.0683%

$1.06M

—

Pieper Steven

See Remarks

$104.52K (2)

$468.18K (4) scheduled

−$363.66K

1,356,053

0.7438%

$11.53M

+7,469%

SHERMAN JEFFREY W

Director

$10.10K (1)

$334.52K (1) scheduled

−$324.42K

224,588

0.1232%

$1.91M

—

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

—

$203.92K (2) scheduled

−$203.92K

150,693

0.0827%

$1.28M

—

PERSKY MARLA

Director

$10.06K (1)

$211.04K (2) scheduled

−$200.99K

157,063

0.0861%

$1.34M

—

Shannon John Patrick Jr

See Remarks

$259.90K (3)

$349.66K (2) scheduled

−$89.76K

2,898,933

1.59%

$24.64M

+8,892%

Brady James Aloysius

Director

—

$60.04K (1) scheduled

−$60.04K

113,359

0.0622%

$963.55K

—

Schmid John P.

Director

$50.13K (5)

—

+$50.13K

138,359

0.0759%

$1.18M

—

PRESTRELSKI STEVEN

Chief Scientific Officer

—

$27.16K (1) scheduled

−$27.16K

719,780

0.3948%

$6.12M

—

Nguyen Anh Tu

See Remarks

—

395,023

0.2167%

$3.36M

+30.4%

JOHNSON KENNETH ERLAND

See Remarks

—

320,446

0.1758%

$2.72M

+3,278%

Kong Garheng

Director

—

238,337

0.1307%

$2.03M

—

Fairley Ricki Louise

Director

—

135,000

0.0740%

$1.15M

—

KREHER NERISSA

Director

—

33,582

0.0184%

$285.45K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Pieper Steven

1 Sep 2026

See Remarks

Sold on a plan

5,000

$8.50

$42.50K

Hecht Beth

1 Sep 2026

See Remarks

Sold on a plan

16,666

$8.49

$141.43K

McCulloch Kevin

1 Sep 2026

See Remarks

Sold on a plan

15,000

$8.49

$127.31K

Pieper Steven

12 Aug 2026

See Remarks

Sold on a plan

5,000

$8.50

$42.50K

Hecht Beth

3 Aug 2026

See Remarks

Sold on a plan

16,666

$8.01

$133.55K

McCulloch Kevin

3 Aug 2026

See Remarks

Sold on a plan

15,000

$8.02

$120.24K

Pieper Steven

7 Jul 2026

See Remarks

Sold on a plan

27,600

$8.52

$235.28K

Pieper Steven

6 Jul 2026

See Remarks

Sold on a plan

17,400

$8.50

$147.90K

Hecht Beth

1 Jul 2026

See Remarks

Sold on a plan

16,666

$8.03

$133.86K

McCulloch Kevin

1 Jul 2026

See Remarks

Sold on a plan

90,000

$8.03

$722.51K

JOHNSON JOHN

4 Jun 2026

Director

Sold on a plan

15,000

$6.09

$91.42K

BORMANN-KENNEDY BARBARA-JEAN ANNE

4 Jun 2026

Director

Sold on a plan

16,000

$6.09

$97.51K

HALKUFF DAWN

4 Jun 2026

Director

Sold on a plan

20,000

$6.09

$121.89K

PERSKY MARLA

3 Jun 2026

Director

Sold on a plan

15,500

$5.90

$91.43K

Hecht Beth

1 Jun 2026

See Remarks

Sold on a plan

16,667

$6.06

$100.98K

Hecht Beth

1 May 2026

See Remarks

Sold on a plan

16,667

$6.23

$103.81K

Hecht Beth

1 Apr 2026

See Remarks

Sold on a plan

16,667

$5.99

$99.86K

Brady James Aloysius

30 Mar 2026

Director

Sold on a plan

10,834

$5.54

$60.04K

McCulloch Kevin

12 Mar 2026

See Remarks

Exercised, kept

$3.94

$15.76

McCulloch Kevin

12 Mar 2026

See Remarks

Exercised, kept

48,894

$4.09

$199.98K

Pieper Steven

5 Mar 2026

See Remarks

Exercised, kept

14,036

$5.93

$83.23K

Pieper Steven

5 Mar 2026

See Remarks

Exercised, kept

27,891

$4.09

$114.07K

Hecht Beth

2 Mar 2026

See Remarks

Sold on a plan

100

$7.06

$706.00

Hecht Beth

2 Mar 2026

See Remarks

Sold on a plan

16,567

$6.24

$103.38K

Hecht Beth

2 Feb 2026

See Remarks

Sell

16,667

$7.45

$124.15K

McCulloch Kevin

8 Jan 2026

See Remarks

Sold on a plan

15,000

$8.00

$120.00K

Shannon John Patrick Jr

5 Jan 2026

See Remarks

Sold after exercise

24,907

$7.08

$176.26K

Hecht Beth

2 Jan 2026

See Remarks

Sold on a plan

16,667

$7.43

$123.78K

JOHNSON JOHN

19 Dec 2025

Director

Sell

135,400

$7.22

$977.02K

BORMANN-KENNEDY BARBARA-JEAN ANNE

12 Dec 2025

Director

Sold on a plan

15,000

$7.09

$106.41K

Hecht Beth

1 Dec 2025

See Remarks

Sold on a plan

16,667

$7.01

$116.78K

Shannon John Patrick Jr

14 Nov 2025

See Remarks

Exercised, kept

87,100

$1.55

$135.01K

Shannon John Patrick Jr

13 Nov 2025

See Remarks

Sold after exercise

23,242

$7.46

$173.40K

Hecht Beth

11 Nov 2025

See Remarks

Sold on a plan

16,667

$7.40

$123.30K

PERSKY MARLA

11 Sep 2025

Director

Sold on a plan

15,500

$7.72

$119.61K

SHERMAN JEFFREY W

28 Aug 2025

Director

Sold after exercise

42,232

$7.92

$334.52K

JOHNSON JOHN

13 Aug 2025

Director

Sell

107,500

$7.32

$786.46K

HALKUFF DAWN

12 Aug 2025

Director

Sell

42,500

$7.28

$309.23K

McCulloch Kevin

13 Jun 2025

See Remarks

Buy

25,000

$4.38

$109.48K

Hecht Beth

20 Mar 2025

See Remarks

Sell

40,000

$5.43

$217.24K

Pieper Steven

22 Nov 2024

See Remarks

Exercised, kept

19,483

$1.55

$30.20K

Schmid John P.

12 Aug 2024

Director

Buy indirect

4,515

$2.25

$10.15K

Schmid John P.

9 Aug 2024

Director

Buy indirect

4,285

$2.37

$10.13K

Schmid John P.

10 May 2024

Director

Buy indirect

5,400

$1.91

$10.31K

JOHNSON JOHN

18 Mar 2024

Director

Exercised, kept

215,600

$1.99

$429.04K

Schmid John P.

14 Mar 2024

Director

Buy indirect

4,500

$2.16

$9.72K

SHERMAN JEFFREY W

27 Nov 2023

Director

Buy indirect

5,400

$1.87

$10.10K

Pieper Steven

20 Nov 2023

See Remarks

Buy

28,000

$1.95

$54.60K

HALKUFF DAWN

20 Nov 2023

Director

Buy indirect

5,410

$1.84

$9.95K

Shannon John Patrick Jr

17 Nov 2023

See Remarks

Buy

30,769

$1.64

$50.40K

Schmid John P.

16 Nov 2023

Director

Buy indirect

6,500

$1.51

$9.82K

PERSKY MARLA

14 Nov 2023

Director

Buy indirect

6,370

$1.58

$10.06K

Edick Paul R

9 Aug 2023

See Remarks

Buy

10,000

$2.38

$23.79K

Edick Paul R

13 Dec 2022

See Remarks

Buy

20,000

$1.45

$29.00K

Edick Paul R

12 May 2022

See Remarks

Buy

100,000

$1.40

$140.38K

PRESTRELSKI STEVEN

22 Feb 2022

Chief Scientific Officer

Sold after exercise

11,228

$2.42

$27.16K

Edick Paul R

15 Nov 2021

See Remarks

Buy indirect

20,000

$2.28

$45.66K

Shannon John Patrick Jr

12 Nov 2021

See Remarks

Buy

60,000

$2.10

$126.00K

Edick Paul R

11 Nov 2021

See Remarks

Buy

200,000

$2.08

$415.76K

Shannon John Patrick Jr

11 Nov 2021

See Remarks

Buy

40,000

$2.09

$83.50K

Pieper Steven

10 Nov 2021

See Remarks

Buy

25,000

$2.00

$49.92K

Xeris Biopharma Holdings, Inc.

By person

Individual transactions

What was left out